Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2018

  • ID: 4577256
  • Report
  • 353 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AIS Inc.
  • Columbia University
  • Endurance Rhythm Inc.
  • Krisara Engineering, LLC
  • NewPace Ltd
  • Spectranetics Corp
  • MORE
Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiac Rhythm Management Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Rhythm Management Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the author's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Rhythm Management Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AIS Inc.
  • Columbia University
  • Endurance Rhythm Inc.
  • Krisara Engineering, LLC
  • NewPace Ltd
  • Spectranetics Corp
  • MORE
1 Table of Contents

2 Introduction
2.1 Cardiac Rhythm Management Devices Overview

3 Products under Development
3.1 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
3.2 Cardiac Rhythm Management Devices - Pipeline Products by Segment
3.3 Cardiac Rhythm Management Devices - Pipeline Products by Territory
3.4 Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
3.5 Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
3.6 Cardiac Rhythm Management Devices - Ongoing Clinical Trials

4 Cardiac Rhythm Management Devices - Pipeline Products under Development by Companies
4.1 Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
4.2 Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development

5 Cardiac Rhythm Management Devices Companies and Product Overview
5.1 A3 Remote Monitoring Technologies Pvt. Ltd. Company Overview
5.2 AI Medical Semiconductor Ltd. Company Overview
5.3 AIS Inc. Company Overview
5.4 Angel Medical Systems Inc Company Overview
5.5 BackBeat Medical, Inc. Company Overview
5.6 Ben-Gurion University of the Negev Company Overview
5.7 Boston Scientific Corp Company Overview
5.8 Boston TransTec LLC Company Overview
5.9 CardiaLen, Inc. Company Overview
5.10 Cardioalarm, Inc Company Overview
5.11 Children’s National Health System Company Overview
5.12 Columbia University Company Overview
5.13 Corhythm Inc Company Overview
5.14 CVRx Inc Company Overview
5.15 DHS Medical Company Overview
5.16 Drexel University Company Overview
5.17 Duke University Company Overview
5.18 EBR Systems Inc Company Overview
5.19 Endurance Rhythm Inc. Company Overview
5.20 Hadasit Medical Research Services and Development Ltd Company Overview
5.21 Impulse Dynamics NV Company Overview
5.22 Imricor Medical Systems Inc Company Overview
5.23 InnerPulse Inc (Inactive) Company Overview
5.24 Integer Holdings Corp Company Overview
5.25 IRadimed Corp Company Overview
5.26 Johns Hopkins University Company Overview
5.27 Kenergy Inc. Company Overview
5.28 Krisara Engineering, LLC Company Overview
5.29 LivaNova PLC Company Overview
5.30 Massachusetts General Hospital Company Overview
5.31 Mathematical Bio-Solutions Inc. Company Overview
5.32 Max Planck Institute for Dynamics and Self-Organization Company Overview
5.33 Mayo Clinic Company Overview
5.34 Medtronic plc Company Overview
5.35 MicroPort Scientific Corp Company Overview
5.36 NanoLinea Company Overview
5.37 NDSU Research Foundation Company Overview
5.38 NewPace Ltd Company Overview
5.39 NuVascular Technologies Inc Company Overview
5.40 Odem Medical Ltd Company Overview
5.41 Ohio State University Company Overview
5.42 Osypka Medical GmbH Company Overview
5.43 Perpetuum Ltd. Company Overview
5.44 Queen Mary University of London Company Overview
5.45 Rice University Company Overview
5.46 Rochester Institute of Technology Company Overview
5.47 Seoul National University Hospital Company Overview
5.48 Shaanxi Qinming Medical Instruments Co Ltd Company Overview
5.49 Shanghai MicroPort Medical Group Co Ltd Company Overview
5.50 Silver Bullet Therapeutics, Inc. Company Overview
5.51 Smartwave Medical Ltd (Inactive) Company Overview
5.52 Spectranetics Corp Company Overview
5.53 St. Jude Medical LLC Company Overview
5.54 SUNY Downstate Medical Center Company Overview
5.55 Teleflex Inc Company Overview
5.56 TransWorld Med Corp Company Overview
5.57 U.S. Stem Cell Inc Company Overview
5.58 University of Bern Company Overview
5.59 University of California Los Angeles Company Overview
5.60 University of Glasgow Company Overview
5.61 University of Michigan Company Overview
5.62 University of Southern California Company Overview
5.63 University of Utah Company Overview

6 Cardiac Rhythm Management Devices- Recent Developments
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.3 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO
6.4 May 15, 2018: MRI Interventions Announces First Quarter 2018 Results
6.5 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration
6.6 May 11, 2018: Boston Scientific Announces Real-World Data Demonstrating Success Of SMART Pass On The S-ICD System
6.7 May 11, 2018: Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy
6.8 May 11, 2018: New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony
6.9 May 10, 2018: FIX-HF-5C Late-Breaking Clinical Trial Data Presented at HRS 2018 with Simultaneous Publication in the JACC: Heart Failure
6.10 May 09, 2018: Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use
6.11 May 09, 2018: U.S. Stem Cell Reports First Quarter Results
6.12 May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results
6.13 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.14 May 03, 2018: Integer Holdings Reports First Quarter 2018 Results
6.15 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
6.16 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
6.17 May 02, 2018: iRhythm Technologies Announces First Quarter Financial Results
6.18 May 01, 2018: Stereotaxis Announces Publication of Clinical Research Supplement Highlighting Robotic Navigation for Cardiac Arrhythmias
6.19 Apr 30, 2018: Orthofix Announces First Quarter 2018 Financial Results
6.20 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.21 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results
6.22 Apr 23, 2018: Philips First Quarter Results 2018
6.23 Apr 19, 2018: Philips showcases dedicated radiation oncology workflow solutions spanning image acquisition to treatment planning at ESTRO 2018
6.24 Apr 16, 2018: USRM Reports 2017 Financial Results
6.25 Apr 10, 2018: iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors
6.26 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.27 Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director
6.28 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.29 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.30 Mar 26, 2018: Solid ion conductors could improve pacemaker safety and reliability
6.31 Mar 19, 2018: Texas Cardiac Arrhythmia Institute at St. David's Medical Center draws cardiac experts from across the globe for EPLive 2018
6.32 Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders
6.33 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales
6.34 Mar 13, 2018: Orthofix Announces Appointment of John Sicard to Board of Directors
6.35 Mar 10, 2018: LifeVest Wearable Defibrillator Reduces Total Mortality By 36 Percent At 90 Days
6.36 Mar 07, 2018: EBR Systems Initiates Global Trial of World’s Only Wireless CRT Pacing Technology
6.37 Mar 07, 2018: Philips again ranks first in ‘medical technology’ patents filed at the European Patent Office
6.38 Mar 06, 2018: Presbyterian Heart and Vascular Care First Team in Albuquerque to Offer the World’s Smallest Pacemaker
6.39 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results
6.40 Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update
6.41 Mar 01, 2018: Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker
6.42 Mar 01, 2018: Safety and Effectiveness of BioTrace Medical’s Tempo Lead Further Demonstrated in Multi-Center Analysis of More Than 200 Cardiac Procedures
6.43 Mar 01, 2018: First BIOTRONIK Pacemakers in Japan Approved for 3 Tesla Full-Body MRIs
6.44 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
6.45 Feb 27, 2018: genedrive Receives Significant Funding for TB Test Development
6.46 Feb 26, 2018: Medtronic Recalls Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillators Due to Manufacturing Error Preventing Electrical Shock Delivery
6.47 Feb 26, 2018: Tissue Regenix Group: Launch of TRX BioSurgery and new distributor agreement
6.48 Feb 26, 2018: Orthofix International Reports Fourth Quarter And Fiscal 2017 Financial Results
6.49 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017
6.50 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives
6.51 Feb 21, 2018: NICE Issues Medtech Innovation Briefing Recognizing Medtronic Reveal LINQ in the Detection of Atrial Fibrillation After Stroke of Unknown Cause
6.52 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
6.53 Feb 13, 2018: Proteus Digital Health Appoints Joseph Swedish As Board Director
6.54 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors
6.55 Feb 08, 2018: Defibtech Receives U.S. FDA Premarket Approval (PMA) for AEDs
6.56 Feb 08, 2018: MemorialCare Saddleback Medical Center Offers World’s Smallest Pacemaker the Size of a Vitamin Weighing Less Than a Penny
6.57 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
6.58 Feb 07, 2018: TMC: Small Device Promises Big Fix
6.59 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
6.60 Feb 06, 2018: New device trial for heart failure patients in Scotland
6.61 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
6.62 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
6.63 Feb 05, 2018: T2 Biosystems Names John Sprague As CFO
6.64 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.65 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
6.66 Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017
6.67 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.68 Jan 25, 2018: MSC Hosts Product Launch of Rega Family Implantable Pacemakers
6.69 Jan 17, 2018: Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in Texas to Use New Smartphone Compatible, Insertable Cardiac Monitor
6.70 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move
6.71 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America
6.72 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.73 Jan 09, 2018: Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results
6.74 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
6.75 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results
6.76 Jan 03, 2018: New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Fortify Assura Implantable Cardioverter Defibrillator
6.77 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer
6.78 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Table 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Table 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials
Table 7: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table 9: A3 Remote Monitoring Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Wireless Device - Wearable Cardiac Rhythm Management System - Product Status
Table 11: Wireless Device - Wearable Cardiac Rhythm Management System - Product Description
Table 12: AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Adaptive CRT And Vagal Stimulation Device - Product Status
Table 14: Adaptive CRT And Vagal Stimulation Device - Product Description
Table 15: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Guardian - Product Status
Table 17: Guardian - Product Description
Table 18: Angel Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Acute Ischemia Monitor - Product Status
Table 20: Acute Ischemia Monitor - Product Description
Table 21: BackBeat Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Moderato - Product Status
Table 23: Moderato - Product Description
Table 24: BackBeat Medical, Inc. - Ongoing Clinical Trials Overview
Table 25: Moderato - Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients with Hypertension - A Double-Blind Randomized Trial - PV Loops Sub Study
Table 26: Moderato - Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients with Hypertension: A Double-blind Randomized Trial
Table 27: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Heart Pacing System - Product Status
Table 29: Heart Pacing System - Product Description
Table 30: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Acuity X4 Quad LV Lead - 1.5T MRI - Product Status
Table 32: Acuity X4 Quad LV Lead - 1.5T MRI - Product Description
Table 33: Acuity X4 Quad LV Lead - 3T MRI - Product Status
Table 34: Acuity X4 Quad LV Lead - 3T MRI - Product Description
Table 35: EMBLEM MRI S-ICD System - Aged Patients - Product Status
Table 36: EMBLEM MRI S-ICD System - Aged Patients - Product Description
Table 37: EMPOWER Leadless Pacer - Product Status
Table 38: EMPOWER Leadless Pacer - Product Description
Table 39: ICM Monitoring & Dx - Product Status
Table 40: ICM Monitoring & Dx - Product Description
Table 41: INGENIO 2 PG - MICS - Product Status
Table 42: INGENIO 2 PG - MICS - Product Description
Table 43: Loop Recorder - Product Status
Table 44: Loop Recorder - Product Description
Table 45: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Status
Table 46: MRI-Safe Implantable Cardiac Rhythm Management Lead - Product Description
Table 47: Next Generation ICD Lead - Product Status
Table 48: Next Generation ICD Lead - Product Description
Table 49: Next Generation ICD/CRT-D - Product Status
Table 50: Next Generation ICD/CRT-D - Product Description
Table 51: Next Generation Quad Polar CRT-D - Product Status
Table 52: Next Generation Quad Polar CRT-D - Product Description
Table 53: NG3 Non Quad System - Product Status
Table 54: NG3 Non Quad System - Product Description
Table 55: Reliance 4-Front Lead - Product Status
Table 56: Reliance 4-Front Lead - Product Description
Table 57: S-ICD System 1.5 - Product Status
Table 58: S-ICD System 1.5 - Product Description
Table 59: S-ICD System 2.0 - Product Status
Table 60: S-ICD System 2.0 - Product Description
Table 61: Temporary RV VVI pacing - Product Status
Table 62: Temporary RV VVI pacing - Product Description
Table 63: VITALITY NXT Defibrillator - Product Status
Table 64: VITALITY NXT Defibrillator - Product Description
Table 65: X4 SYSTEM + QUAD LEAD - Product Status
Table 66: X4 SYSTEM + QUAD LEAD - Product Description
Table 67: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 68: Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Table 69: Reliance 4-Front Lead - Evaluation of Acuity X4 Quadripolar Coronary Venous Leads and Reliance 4-Front Defibrillation Leads: NAVIGATE X4
Table 70: Reliance 4-Front Lead - Expanding MRI Access for Patients with New and Existing ICDs and CRT-Ds: ENABLE MRI
Table 71: S-ICD System 2.0 - A Prospective Randomized Comparative Trial of Subcutaneous Implantable Cardioverter-Defibrillator Implantation with and Without Defibrillation Testing
Table 72: S-ICD System 1.5 - A Prospective Randomized Comparative Trial of Subcutaneous Implantable Cardioverter-Defibrillator Implantation with and Without Defibrillation Testing
Table 73: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator: MADIT S-ICD
Table 74: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Raul Pacemaker - Product Status
Table 76: Raul Pacemaker - Product Description
Table 77: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 78: CardiaLen Device - Atrial Fibrillation - Product Status
Table 79: CardiaLen Device - Atrial Fibrillation - Product Description
Table 80: CardiaLen Device - Ventricular Arrhythmia - Product Status
Table 81: CardiaLen Device - Ventricular Arrhythmia - Product Description
Table 82: Cardioalarm, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 83: CardioAlarm System - Product Status
Table 84: CardioAlarm System - Product Description
Table 85: Children’s National Health System Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Delivery Tool - Epicardial Pacing And Defibrillation - Product Status
Table 87: Delivery Tool - Epicardial Pacing And Defibrillation - Product Description
Table 88: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Biological Pacemaker - Product Status
Table 90: Biological Pacemaker - Product Description
Table 91: Corhythm Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Corhythm Implantable Device - Product Status
Table 93: Corhythm Implantable Device - Product Description
Table 94: CVRx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Barostim neo - Heart Failure - Product Status
Table 96: Barostim neo - Heart Failure - Product Description
Table 97: CVRx Inc - Ongoing Clinical Trials Overview
Table 98: Barostim neo - Heart Failure - Barostim HOPE4HF Study
Table 99: Barostim neo - Heart Failure - Barostim Neo - Baroreflex Activation Therapy for Heart Failure
Table 100: Barostim neo - Heart Failure - Barostim Therapy In Heart Failure With Preserved Ejection Fraction (HFPEF)
Table 101: Barostim neo - Heart Failure - Barostim Therapy in Heart Failure with Reduced Ejection Fraction: A Post-Market Registry with the CE-Marked Barostim Neo System
Table 102: Barostim neo - Heart Failure - Evaluation of Baroreflex Activation Therapy in Patients with Advanced Heart Failure
Table 103: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 104: Drimmer - Product Status
Table 105: Drimmer - Product Description
Table 106: Twistek - Product Status
Table 107: Twistek - Product Description
Table 108: Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Conductance Controller Implant - Product Status
Table 110: Conductance Controller Implant - Product Description
Table 111: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Tissue-Engineered Autonomous Pacemaker - Product Status
Table 113: Tissue-Engineered Autonomous Pacemaker - Product Description
Table 114: EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Second Generation WiSE CRT System - Product Status
Table 116: Second Generation WiSE CRT System - Product Description
Table 117: WiSE CRT System - Product Status
Table 118: WiSE CRT System - Product Description
Table 119: EBR Systems Inc - Ongoing Clinical Trials Overview
Table 120: WiSE CRT System - Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy
Table 121: WiSE CRT System - Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients: SOLVE CRT
Table 122: WiSE CRT System - WiCS-LV Post Market Surveillance Registry
Table 123: Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 124: Endurance Rhythm Micro-Generator - Product Status
Table 125: Endurance Rhythm Micro-Generator - Product Description
Table 126: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Aortic Pacemaker - Product Status
Table 128: Aortic Pacemaker - Product Description
Table 129: Impulse Dynamics NV Pipeline Products & Ongoing Clinical Trials Overview
Table 130: Optimizer IVs System - Product Status
Table 131: Optimizer IVs System - Product Description
Table 132: Optimizer Smart - Product Status
Table 133: Optimizer Smart - Product Description
Table 134: Impulse Dynamics NV - Ongoing Clinical Trials Overview
Table 135: Optimizer IVs System - Evaluation of the Safety and Efficacy of the OPTIMIZER System in Subjects with Moderate-to-Severe Heart Failure with Ejection Fraction Between 25% and 45%: FIX-HF-5C
Table 136: Optimizer Smart - Cardiac Contractility Modulation (CCM) Therapy in Subjects with Heart Failure with Preserved Ejection Fraction
Table 137: Optimizer Smart - Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System in Subjects with Moderate-to-severe Heart Failure with Ejection Fraction Between 25% and 45%: FIX-HF-5CA
Table 138: Optimizer Smart - FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER Smart System in Subjects with Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Table 139: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Magnetic Resonance Imaging (MRI) Compatible Lead - Product Status
Table 141: Magnetic Resonance Imaging (MRI) Compatible Lead - Product Description
Table 142: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 143: InnerPulse Pacemaker - Product Status
Table 144: InnerPulse Pacemaker - Product Description
Table 145: PICD - Product Status
Table 146: PICD - Product Description
Table 147: Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Figure 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment
Figure 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory
Figure 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
Figure 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
Figure 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • A3 Remote Monitoring Technologies Pvt. Ltd.
  • AI Medical Semiconductor Ltd.
  • AIS Inc.
  • Angel Medical Systems Inc
  • BackBeat Medical, Inc.
  • Ben-Gurion University of the Negev
  • Boston Scientific Corp
  • Boston TransTec LLC
  • CardiaLen, Inc.
  • Cardioalarm, Inc
  • Children’s National Health System
  • Columbia University
  • Corhythm Inc
  • CVRx Inc
  • DHS Medical
  • Drexel University
  • Duke University
  • EBR Systems Inc
  • Endurance Rhythm Inc.
  • Hadasit Medical Research Services and Development Ltd
  • Impulse Dynamics NV
  • Imricor Medical Systems Inc
  • InnerPulse Inc
  • Integer Holdings Corp
  • IRadimed Corp
  • Johns Hopkins University
  • Kenergy Inc.
  • Krisara Engineering, LLC
  • LivaNova PLC
  • Massachusetts General Hospital
  • Mathematical Bio-Solutions Inc.
  • Max Planck Institute for Dynamics and Self-Organization
  • Mayo Clinic
  • Medtronic plc
  • MicroPort Scientific Corp
  • NanoLinea
  • NDSU Research Foundation
  • NewPace Ltd
  • NuVascular Technologies Inc
  • Odem Medical Ltd
  • Ohio State University
  • Osypka Medical GmbH
  • Perpetuum Ltd.
  • Queen Mary University of London
  • Rice University
  • Rochester Institute of Technology
  • Seoul National University Hospital
  • Shaanxi Qinming Medical Instruments Co Ltd
  • Shanghai MicroPort Medical Group Co Ltd
  • Silver Bullet Therapeutics, Inc.
  • Smartwave Medical Ltd
  • Spectranetics Corp
  • St. Jude Medical LLC
  • SUNY Downstate Medical Center
  • Teleflex Inc
  • TransWorld Med Corp
  • U.S. Stem Cell Inc
  • University of Bern
  • University of California Los Angeles
  • University of Glasgow
  • University of Michigan
  • University of Southern California
  • University of Utah
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll